Colorectal cancer outcomes among Hispanic/Latino patients in the United States: a scoping review protocol.

IF 1.5 Q3 HEALTH CARE SCIENCES & SERVICES
Joel Sanchez-Mendez, Juanita Elizabeth Quino, Wei Xiong, Mariana C Stern
{"title":"Colorectal cancer outcomes among Hispanic/Latino patients in the United States: a scoping review protocol.","authors":"Joel Sanchez-Mendez, Juanita Elizabeth Quino, Wei Xiong, Mariana C Stern","doi":"10.11124/JBIES-23-00296","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>This scoping review will identify the patterns of survival, treatment, and recurrence among Hispanic and/or Latino/a/x (H/L) patients with colorectal cancer (CRC) living in the United States (US) and Puerto Rico. Additionally, population- and individual-level determinants of cancer outcomes among H/L CRC patients will be mapped to highlight under-reported/under-investigated research areas.</p><p><strong>Introduction: </strong>CRC is the third most common cancer excluding skin cancers in the US. Unlike non-Hispanic White populations, cancer is the number one cause of death in H/L populations and currently represents 21% of total deaths. Despite this, a lack of consensus exists on CRC outcomes for H/L patients. Most research on H/L individuals has examined incidence and screening of CRC, with fewer studies focusing on cancer outcomes.</p><p><strong>Inclusion criteria: </strong>All epidemiological study designs and systematic reviews will be considered. The review will only include peer-reviewed studies that report on survival, treatment, and/or recurrence patterns for H/L patients with CRC residing in the US and Puerto Rico.</p><p><strong>Methods: </strong>A 3-step search with a 2-stage study selection process will be followed, as recommended by JBI and Arksey and O'Malley. Databases to be searched will include MEDLINE (PubMed), Embase (Ovid), and Scopus. A data extraction tool will be designed based on JBI recommendations. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRSIMA-ScR) will be used, with the results presented in a PRISMA diagram. Publications in English from database inception to the present will be considered.</p><p><strong>Review registration: </strong>Open Science Framework https://osf.io/y6qf5.</p>","PeriodicalId":36399,"journal":{"name":"JBI evidence synthesis","volume":" ","pages":"1347-1354"},"PeriodicalIF":1.5000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11236500/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"JBI evidence synthesis","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.11124/JBIES-23-00296","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEALTH CARE SCIENCES & SERVICES","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: This scoping review will identify the patterns of survival, treatment, and recurrence among Hispanic and/or Latino/a/x (H/L) patients with colorectal cancer (CRC) living in the United States (US) and Puerto Rico. Additionally, population- and individual-level determinants of cancer outcomes among H/L CRC patients will be mapped to highlight under-reported/under-investigated research areas.

Introduction: CRC is the third most common cancer excluding skin cancers in the US. Unlike non-Hispanic White populations, cancer is the number one cause of death in H/L populations and currently represents 21% of total deaths. Despite this, a lack of consensus exists on CRC outcomes for H/L patients. Most research on H/L individuals has examined incidence and screening of CRC, with fewer studies focusing on cancer outcomes.

Inclusion criteria: All epidemiological study designs and systematic reviews will be considered. The review will only include peer-reviewed studies that report on survival, treatment, and/or recurrence patterns for H/L patients with CRC residing in the US and Puerto Rico.

Methods: A 3-step search with a 2-stage study selection process will be followed, as recommended by JBI and Arksey and O'Malley. Databases to be searched will include MEDLINE (PubMed), Embase (Ovid), and Scopus. A data extraction tool will be designed based on JBI recommendations. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRSIMA-ScR) will be used, with the results presented in a PRISMA diagram. Publications in English from database inception to the present will be considered.

Review registration: Open Science Framework https://osf.io/y6qf5.

美国西班牙裔/拉美裔患者的结直肠癌治疗效果:范围界定审查协议。
目的:本范围界定综述将确定居住在美国和波多黎各的西班牙裔和/或拉丁裔/a/x(H/L)结直肠癌(CRC)患者的生存、治疗和复发模式。此外,还将绘制西班牙裔和/或拉丁裔/a/x(H/L)结直肠癌患者癌症预后的人口和个人层面决定因素图,以突出报告不足/调查不足的研究领域:在美国,除皮肤癌外,CRC 是第三大常见癌症。与非西班牙裔白人不同,癌症是导致男/女患者死亡的头号原因,目前占总死亡人数的 21%。尽管如此,人们对男/女患者的 CRC 结果仍缺乏共识。大多数针对男/女患者的研究都是针对 CRC 的发病率和筛查,而关注癌症治疗效果的研究较少:所有流行病学研究设计和系统综述都将被考虑在内。综述只包括同行评审的研究,这些研究报告了居住在美国和波多黎各的 H/L CRC 患者的生存、治疗和/或复发模式:方法:将按照 JBI 和 Arksey 及 O'Malley 的建议,分三步进行检索,并进行两阶段的研究筛选。要检索的数据库包括 MEDLINE (PubMed)、Embase (Ovid) 和 Scopus。将根据 JBI 的建议设计数据提取工具。将使用 "系统综述和荟萃分析首选报告项目"(PRSIMA-ScR),并以 PRISMA 图表展示结果。将考虑从数据库建立至今的英文出版物。该协议已在开放科学框架中注册:https://osf.io/y6qf5。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
JBI evidence synthesis
JBI evidence synthesis Nursing-Nursing (all)
CiteScore
4.50
自引率
3.70%
发文量
218
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信